CYBIN INC. current report, Q2 FY2023

Business Context and Reporting Period

Cybin Inc. filed a Form 6-K as a foreign private issuer for June 2023. The filing was signed on June 8, 2023, and lists the company’s principal executive offices in Toronto, Ontario.

Financial and Operating Metrics

The provided filing text does not include revenue, profit, cash flow, margins, debt, liquidity, clinical-development metrics, or other financial results.

Material Changes Versus Prior Period

The filing text does not provide comparative-period information or identify material changes in the company’s financial or operating condition.

Guidance, Outlook, Risks, and Unusual Items

The filing identifies an exhibit described as a news release dated June 8, 2023, but the release itself is not included in the provided text. Accordingly, no guidance, outlook, management commentary, risks, contingencies, or unusual items can be summarized.

Investor Verification Items

  • Obtain and review Exhibit 99.1, the June 8, 2023 news release.
  • Verify whether the omitted exhibit contains financial, clinical, financing, or corporate-development information.
  • Consult Cybin’s applicable annual and interim reports for revenue, cash position, liquidity, financing needs, and risk disclosures.